4751-48-8
4751-48-8
Chemical Structure
ST91 free base
- CAS. Nr.: 4751-48-8
- Formula:C13H19N3
- Molecular Weight:217.31
InChIKey: IALHTUPVRAQZFI-UHFFFAOYSA-N
SMILES: CCC1=C(C(CC)=CC=C1)NC2=NCCN2
Biological Activity: ST91 free base is a α2-adrenoceptor (α2AR) agonist. ST91 free base activates both α2AAR and non-α2AAR subtypes to produce spinal antinociception[1][2][3].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ST91 free base | ST91 free base is a α2-adrenoceptor (α2AR) agonist. ST91 free base activates both α2AAR and non-α2AAR subtypes to produce spinal antinociception. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Graham BA, et, al. Synergistic interactions between two alpha(2)-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague-Dawley rats. Pain. 2000 Mar;85(1-2):135-43. [Content Brief]
- [2]. Maccari S, et, al. α-Adrenoceptor stimulation attenuates melanoma growth in mice. Br J Pharmacol. 2022 Apr;179(7):1371-1383. [Content Brief]
- [3]. Stone LS, et, al. ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors. J Pharmacol Exp Ther. 2007 Dec;323(3):899-906. [Content Brief]
